Second Degree AVB - Mobitz II

1. Executive Overview: What is Second Degree AV Block Mobitz II?

Second Degree Atrioventricular Block (AVB) Mobitz II is a serious cardiac conduction disorder characterized by intermittent failure of the electrical impulses to travel from the atria to the ventricles. Unlike Mobitz I (Wenckebach), where the PR interval progressively lengthens before a dropped beat, Mobitz II is defined by a sudden, unexpected failure of conduction without prior PR interval prolongation.

In clinical terms, Mobitz II represents a high-grade pathology of the His-Purkinje system. It occurs when the electrical signal is blocked below the level of the Atrioventricular (AV) node, typically within the Bundle of His or the bundle branches. Because this block is infra-nodal, it carries a significant risk of progressing to Third Degree (Complete) Heart Block, which can lead to syncope, hemodynamic collapse, or sudden cardiac death.

ICD-10 Classification: I44.1 (Atrioventricular block, second degree)

2. Pathophysiology, Etiology, and Risk Factors

The Pathophysiological Mechanism

The heart’s electrical system relies on a precise sequence of depolarization. In a healthy heart, the impulse originates in the Sinoatrial (SA) node, travels through the atria to the AV node, and proceeds down the His-Purkinje system.

In Mobitz II, the AV node functions correctly, but the infra-nodal conduction system (His bundle or bundle branches) is diseased. When the system fails, the impulse simply "stops." Consequently, on an Electrocardiogram (ECG), you will see P-waves that are not followed by a QRS complex, occurring without the "warning" of a lengthening PR interval.

Etiology and Common Causes

Mobitz II is almost always indicative of structural heart disease. Common etiologies include:

• Degenerative Fibrosis: Lenegre’s disease or Lev’s disease (age-related sclerosis of the conduction system).
• Ischemic Heart Disease: Previous myocardial infarction (specifically anterior wall MI involving the left anterior descending artery).
• Inflammatory/Infectious Processes: Myocarditis, Lyme disease, or sarcoidosis.
• Post-Surgical Complications: Damage to the conduction system following valve replacement or congenital heart defect repair.
• Pharmacological Triggers: Toxicity from beta-blockers, non-dihydropyridine calcium channel blockers (verapamil/diltiazem), or digoxin.

Risk Factors

3. Signs, Symptoms, and Clinical Presentation

Clinical presentation varies widely. Some patients remain asymptomatic, while others face life-threatening consequences.

Common Symptoms

• Syncope/Presyncope: Sudden loss of consciousness caused by transient asystole.
• Bradycardia-Related Fatigue: Chronic tiredness due to low cardiac output.
• Dyspnea: Shortness of breath, often exacerbated by physical exertion.
• Angina: Chest pain resulting from decreased coronary perfusion.
• Palpitations: Sensation of irregular or "skipped" heartbeats.

Physical Exam Findings

• Irregular Pulse: A pulse that periodically "drops" beats.
• Bradycardia: A resting heart rate frequently below 60 bpm.
• Variable S1 Intensity: If the block is intermittent, the intensity of the first heart sound may vary due to the changing timing of atrial and ventricular contractions.

4. Standard Diagnostic Evaluation & Workup

The gold standard for diagnosis is the 12-lead Electrocardiogram (ECG), but a comprehensive workup is required to determine the underlying cause and determine the need for intervention.

1. Electrocardiography (ECG)

• The Hallmark: Intermittent non-conducted P-waves.
• PR Interval: Consistent and stable duration in the conducted beats.
• QRS Complex: Often wide (indicating a bundle branch block pattern).

2. Ambulatory Monitoring

Because Mobitz II can be paroxysmal, a standard 10-second ECG may miss the event.
* Holter Monitor: 24–48 hour recording to capture intermittent blocks.
* Event Recorder/Loop Recorder: For patients with infrequent symptoms, an implantable loop recorder (ILR) can monitor the heart for months.

3. Laboratory Assays

• Cardiac Enzymes: Troponin levels to rule out acute myocardial infarction.
• Electrolytes: Potassium, magnesium, and calcium levels.
• Thyroid Panel: To rule out hypothyroidism, which can exacerbate bradyarrhythmias.

4. Advanced Imaging

• Echocardiogram (TTE): To assess Left Ventricular Ejection Fraction (LVEF) and identify structural anomalies.
• Cardiac MRI: Highly effective for detecting infiltrative diseases like sarcoidosis or myocarditis that affect the conduction system.

5. Therapeutic Interventions

Unlike Mobitz I, which is often benign and observation-based, Mobitz II is considered a malignant rhythm. It is characterized by its unpredictability and high propensity to progress to complete heart block.

Pharmacological Management

There is no "cure" for Mobitz II via medication. In fact, the first step is to discontinue any medications that suppress AV node conduction. If the patient is on beta-blockers or calcium channel blockers, these must be titrated down or stopped under strict medical supervision.

Surgical/Device Therapy (The Standard of Care)

The definitive treatment for symptomatic or high-risk asymptomatic Mobitz II is Permanent Pacemaker (PPM) implantation.

• Indications for Pacemaker:
  • Symptomatic bradycardia.
  • Asymptomatic Mobitz II with wide QRS complexes.
  • Evidence of high-grade AV block during exercise testing.
• Procedure: A transvenous lead system is typically used, with leads placed in the right atrium and right ventricle (Dual-chamber pacing) to maintain AV synchrony.

Lifestyle and Long-Term Prognosis

• Monitoring: Regular follow-ups with a cardiac electrophysiologist are mandatory.
• Prognosis: Excellent with a pacemaker. Without a pacemaker, the risk of sudden cardiac arrest is significantly elevated, making the device life-saving.
• Lifestyle: Patients should avoid stimulants that may exacerbate conduction issues and maintain a heart-healthy diet to manage underlying coronary artery disease.

6. Frequently Asked Questions (FAQ)

1. Is Mobitz II considered a medical emergency?
Yes, it is a high-risk rhythm. If you experience dizziness, fainting, or chest pain, you must seek emergency medical attention immediately.

2. Can Mobitz II be cured with medication?
No. There are no medications to "fix" a damaged conduction system in the His-Purkinje fibers. A pacemaker is usually required.

3. What is the difference between Mobitz I and Mobitz II?
Mobitz I (Wenckebach) involves a lengthening PR interval before a dropped beat and is often benign. Mobitz II involves a sudden dropped beat without PR changes and is dangerous.

4. Will I need open-heart surgery for a pacemaker?
No. Pacemaker implantation is a minimally invasive procedure performed under local anesthesia, usually taking less than two hours.

5. Can I exercise with Mobitz II?
You should avoid strenuous physical activity until you have been evaluated by a cardiologist. Once a pacemaker is implanted, most patients can return to normal activity.

6. Does Mobitz II always lead to a heart attack?
No, but it can be a sign that you have had a heart attack or have underlying coronary artery disease.

7. How long does a pacemaker battery last?
Modern pacemakers typically last between 8 to 12 years before requiring a simple battery replacement.

8. Can stress cause Mobitz II?
Stress can exacerbate symptoms, but the underlying cause is usually structural damage or fibrosis of the heart's electrical system.

9. Is Mobitz II hereditary?
While some conduction system diseases have a genetic component, most cases of Mobitz II are acquired through aging or heart disease.

10. What happens if I ignore Mobitz II?
Ignoring this condition significantly increases the risk of complete heart block, which can result in syncope, falls, or sudden cardiac death.

Related Clinical Integration

In the clinical management of Second Degree AVB - Mobitz II, precise diagnostic evaluation is essential to differentiate between transient conduction disturbances and high-grade blockages that may necessitate permanent pacing. An Electrocardiogram (ECG) / تخطيط القلب الكهربائي (ECG) (خدمات رعاية عامة) serves as the primary diagnostic tool to identify the characteristic intermittent failure of atrial impulses to conduct to the ventricles, which is the hallmark of this condition. While cardiac rhythm monitoring is the priority, clinicians must also remain vigilant for neurological symptoms such as syncope or presyncope; in cases where these symptoms are ambiguous or potentially multifactorial, an Electroencephalogram (EEG) - Routine / تخطيط كهربية الدماغ (EEG) - روتيني (فحص بالمنظار أو أخذ عينات) may be utilized to rule out primary neurological etiologies, ensuring a comprehensive differential diagnosis within our hospital system.